Lamisil Dermgel

Terbinafine, the active ingredient in Lamisil Dermgel, is an allylamine antifungal presented as a gel for cutaneous (topical) use. It treats superficial fungal skin infections such as ringworm, athlete's foot, jock itch and tinea versicolor in patients as prescribed. It is indicated for use on intact skin and is applied once daily for the prescribed duration.

GNH USA supplies Lamisil Dermgel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products and reliable logistics across multiple regions.

Terbinafine is an allylamine antifungal that treats superficial dermatophyte infections of the skin.

- Tinea corporis: reduces lesion size and clears the characteristic ring‑shaped rash. - Tinea pedis: alleviates itching and eliminates fungal growth on the feet. - Tinea cruris: resolves inflammation and scaling in the groin area. - Tinea versicolor: normalizes skin pigmentation by eradicating the causative yeast.

Topical terbinafine may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation after application. - Redness: erythema of the treated skin. - Scaling: flaking or dry skin around the lesion. - Stinging: brief sharp discomfort on contact. - Contact dermatitis: localized allergic skin reaction.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: extensive skin detachment. - Systemic toxicity: rare liver enzyme elevation with extensive use. - Severe skin irritation: persistent ulceration or necrosis. - Anaphylaxis: rapid onset of systemic hypersensitivity.

Before using Lamisil Dermgel, consider the following safety measures.

- Apply to intact skin only: avoid broken or inflamed areas. - Avoid contact with eyes and mucous membranes: wash hands thoroughly after each use. - Do not cover treated area with occlusive dressings: may increase systemic absorption. - Monitor for signs of hypersensitivity: discontinue if rash, swelling, or severe irritation occurs. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine gel has limited systemic absorption, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent oral terbinafine therapy: increases risk of systemic toxicity. - Use with other topical antifungal agents: may cause excessive local irritation.

Moderate Interactions (Monitor Closely): - Co‑administration with topical corticosteroids: may mask local irritation. - Use with occlusive bandages: can raise systemic absorption. - Combination with photosensitizing drugs: may increase sun sensitivity.